200 related articles for article (PubMed ID: 31487000)
1. External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants.
Chai SY; Peng R; Zhang R; Zhou L; Pillay N; Tay KH; Badrick T; Li J; Horan MP
Pathol Oncol Res; 2020 Jul; 26(3):1595-1603. PubMed ID: 31487000
[TBL] [Abstract][Full Text] [Related]
2. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA).
Haselmann V; Ahmad-Nejad P; Geilenkeuser WJ; Duda A; Gabor M; Eichner R; Patton S; Neumaier M
Clin Chem Lab Med; 2018 Jan; 56(2):220-228. PubMed ID: 28841569
[TBL] [Abstract][Full Text] [Related]
3. International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.
Keppens C; Dequeker EMC; Patton SJ; Normanno N; Fenizia F; Butler R; Cheetham M; Fairley JA; Williams H; Hall JA; Schuuring E; Deans ZC;
BMC Cancer; 2018 Aug; 18(1):804. PubMed ID: 30092778
[TBL] [Abstract][Full Text] [Related]
4. Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.
Fairley JA; Cheetham MH; Patton SJ; Rouleau E; Denis M; Dequeker EMC; Schuuring E; van Casteren K; Fenizia F; Normanno N; Deans ZC
BMC Cancer; 2022 Jul; 22(1):759. PubMed ID: 35820813
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study for Detection of
Kim Y; Shin S; Lee KA
Biomed Res Int; 2018; 2018():7392419. PubMed ID: 29854785
[TBL] [Abstract][Full Text] [Related]
6. Results of the UK NEQAS for Molecular Genetics reference sample analysis.
Richman SD; Fairley J; Hall JA; Nataraj N; Bhide M; Lau A; Norman KL; Deans ZC
J Clin Pathol; 2018 Nov; 71(11):989-994. PubMed ID: 30030291
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
[TBL] [Abstract][Full Text] [Related]
8. External quality assurance program for PCR amplification of genomic DNA: an Italian experience.
Raggi CC; Pinzani P; Paradiso A; Pazzagli M; Orlando C
Clin Chem; 2003 May; 49(5):782-91. PubMed ID: 12709370
[TBL] [Abstract][Full Text] [Related]
9. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
[TBL] [Abstract][Full Text] [Related]
10. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.
He HJ; Stein EV; Konigshofer Y; Forbes T; Tomson FL; Garlick R; Yamada E; Godfrey T; Abe T; Tamura K; Borges M; Goggins M; Elmore S; Gulley ML; Larson JL; Ringel L; Haynes BC; Karlovich C; Williams PM; Garnett A; Ståhlberg A; Filges S; Sorbara L; Young MR; Srivastava S; Cole KD
J Mol Diagn; 2019 Jul; 21(4):658-676. PubMed ID: 31055023
[TBL] [Abstract][Full Text] [Related]
11. One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants.
Gutowska-Ding MW; Deans ZC; Roos C; Matilainen J; Khawaja F; Brügger K; Ahn JW; Boustred C; Patton SJ
Eur J Hum Genet; 2020 Feb; 28(2):202-212. PubMed ID: 31570784
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan.
Ho HL; Huang CC; Ku WH; Ho CL; Lin CH; Yu SL; Chou TY
J Chin Med Assoc; 2019 Jun; 82(6):473-476. PubMed ID: 30932938
[TBL] [Abstract][Full Text] [Related]
13. Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.
Devereaux KA; Souers RJ; Merker JD; Lindeman NI; Graham RP; Hameed MR; Vasalos P; Moncur JT; Lockwood CM; Xian RR
Arch Pathol Lab Med; 2023 Apr; 147(4):425-433. PubMed ID: 35687785
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
15. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
[TBL] [Abstract][Full Text] [Related]
16. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
Yang SR; Mooney KL; Libiran P; Jones CD; Joshi R; Lau HD; Stehr H; Berry GJ; Zehnder JL; Long SR; Kong CS; Kunder CA
Cancer Cytopathol; 2020 Jan; 128(1):43-56. PubMed ID: 31751001
[TBL] [Abstract][Full Text] [Related]
17. Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.
Bartels S; Persing S; Hasemeier B; Schipper E; Kreipe H; Lehmann U
J Mol Diagn; 2017 Sep; 19(5):722-732. PubMed ID: 28723342
[TBL] [Abstract][Full Text] [Related]
18. An external quality assurance trial to assess mass spectrometry protein testing facilities for identifying multiple human peptides.
Horan MP; Hoffmann P; Briggs MT; Condina M; Herbert S; Ito J; Rodger A; McKay M; Maltby D; Crossett B; Abudulai LN; Clarke MW; Badrick T
Anal Bioanal Chem; 2019 Oct; 411(25):6575-6581. PubMed ID: 31384985
[TBL] [Abstract][Full Text] [Related]
19. Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.
Fettke H; Steen JA; Kwan EM; Bukczynska P; Keerthikumar S; Goode D; Docanto M; Ng N; Martelotto L; Hauser C; Southey MC; Azad AA; Nguyen-Dumont T
Biotechniques; 2020 Aug; 69(2):133-140. PubMed ID: 32654508
[TBL] [Abstract][Full Text] [Related]
20. Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy.
Pel J; Choi WWY; Leung A; Shibahara G; Gelinas L; Despotovic M; Ung WL; Marziali A
PLoS One; 2018; 13(10):e0204265. PubMed ID: 30278055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
